Pharmaceuticals, Biotechnology and Life Sciences
MENLO PARK, Calif.–(BUSINESS WIRE)–GRAIL, Inc., a healthcare company whose mission is to detect cancer early, when it can be cured,…
Catabasis Pharmaceuticals has enrolled more than expected patients for its third phase PolarisDMD trial of edasalonexent in Duchenne muscular dystrophy (DMD), for which it expects the top-line results in the fourth quarter of 2020.
Arrowhead Pharmaceuticals have announced participating in several conferences in October, covering cystic fibrosis, Oligonucleotide-Based Therapeutics, and genetic medicines topics.
FDA has approved Invokana (canagliflozin) to treat diabetic kidney disease (DKD) and reduce the risk of hospitalization for heart failure in patients with type 2 diabetes (T2D) and DKD, which is the only diabetes medicine indicated to slow the progression of diabetic nephropathy (also known as DKD) and reduce the risk of hospitalization for heart failure in patients with T2D and DKD.
Lysogene posted net loss, for the first half of 2019 which amounted to €1.9 million compared to €7.2 million in the first half of 2018, with €6.8 million revenues in the first half 2019.
Startup Sandbox graduates are poised to deliver breakthroughs with global impact with innovation spanning next-generation DNA sequencing, drug discovery, and cancer screening to bioceramics, biofoam, and smart gardening.
Transgene posted promising result at ESMO, of TG4001 plus Bavencio (avelumab) in HPV-16 positive cancers, from a clinical trial conducted…
AstraZeneca and Merck’s LYNPARZA reduced the risk of disease progression or death by 51% in men with homologous recombination repair…
– IMvigor130 is the first positive Phase III study of a cancer immunotherapy combination in people with previously untreated advanced…
Opdivo demonstrated a 23% reduction in the risk of death and 2.5-month improvement in median overall survival compared to chemotherapy, according to results from Phase 3 ATTRACTION-3 trial to be featured in a Presidential Symposium during the European Society for Medical Oncology 2019 Annual Congress.